Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aveo Pharmaceuticals (NQ: AVEO )

8.250 USD +0.040 (+0.49%)
Streaming Delayed Price Updated: 12:01 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 219,231
Open 8.180
Bid (Size) 8.220 (2)
Ask (Size) 8.260 (2)
Prev. Close 8.210
Today's Range 8.040 - 8.420
52wk Range 0.4653 - 10.71
Shares Outstanding 118,867,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA®) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma
AVEO Oncology (Nasdaq: AVEO) today announced the presentation of results from the Phase 1b portion of the Phase 1b/2 DEDUCTIVE clinical trial of tivozanib (FOTIVDA®), AVEO’s vascular endothelial growth... 
From Business Wire News Releases
AVEO Oncology Highlights Recent Progress and 2021 Outlook
AVEO Oncology (Nasdaq: AVEO) today highlighted its recent progress and outlined its 2021 outlook. 
From Business Wire News Releases

Performance

YTD
+38.19%
+38.19%
1 Month
+59.57%
+59.57%
3 Month
+35.47%
+35.47%
6 Month
+78.57%
+78.57%
1 Year
+1184.65%
+1184.65%

More News

Read More
AVEO Oncology Announces Participation at Two Upcoming Investor Conferences
From Business Wire News Releases
AVEO Oncology Announces Webcast of Presentation at the 39th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
AVEO Oncology to Present at the Stifel 2020 Virtual Healthcare Conference
From Business Wire News Releases
AVEO Oncology Reports Third Quarter 2020 Financial Results and Provides Business Update
From Business Wire News Releases
AVEO Oncology and EUSA Pharma Announce Annals of Oncology Publication of Data from Phase 1b/2 TiNivo Study in Renal Cell Carcinoma
From Business Wire News Releases
AVEO Oncology Announces Appointment of David W. Crist as Vice President of Sales
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tags Market News AFMD TLGT
From Benzinga
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
Tags JAGX AVEO VIRI
From Benzinga
The Week Ahead In Biotech (Jan. 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.